Comar said iMARK is supporting its growth objectives in the medical and pharmaceutical industries. The new, combined company will focus on providing Comar’s clients with engineering and custom plastic molding and assembly services. There will be no plant closures or employee layoffs for either company, Comar said.
“We have been proud to serve our customers the last 20 years and look forward to continuing to serve them. We believe Comar’s culture is well-aligned with ours, which is focused on ‘Always the Hard Right – Never the Easy Wrong’ and providing a quality product to the same types of customers as ours. Comar brings a unique set of capabilities that will better serve our customers – full service, in-house design, development, and prototyping with IDworks, scale in procurement, deeper engineering bench with broad set of specializations, and multiple plants with capacity across the US.” Mark Sturtevant will continue to manage day-to-day operations of the iMARK facility and will be fully involved in efforts to serve current and future iMARK and Comar customers,” Mark Sturtevant, president of iMARK, said.
Comar said it has nine manufacturing and distribution locations throughout the United States.
“We are so excited to be welcoming Mark and Linda Sturtevant and their outstanding team to the Comar organization. Over the last 20 years, Mark and Linda have built a high performance, customer-centric team with the best scientific injection molding capabilities we have seen across the industry. They truly know how to serve their customers with parts right the first time … and repeat that reliably. We look forward to partnering with them to better serve our current and prospective customers with new capacity and capabilities. And we look forward to continuing to acquire strategic and complementary businesses like iMARK,” Mark Ruggieri, CEO of Comar, said.
Financial terms were not disclosed.